Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan-Dec:15:21501319241309168.
doi: 10.1177/21501319241309168.

Metabolic Syndrome: An Updated Review on Diagnosis and Treatment for Primary Care Clinicians

Affiliations
Review

Metabolic Syndrome: An Updated Review on Diagnosis and Treatment for Primary Care Clinicians

Carolyn Mae Peterseim et al. J Prim Care Community Health. 2024 Jan-Dec.

Abstract

Objective: Metabolic syndrome is a cluster of cardiovascular risk factors (central obesity, hypertension, dyslipidemia, and insulin resistance) that affects between 12.5% and 31.4% of adults worldwide. It correlates with increased risks of cardiovascular disease, diabetes, cancer, and overall mortality in a dose-dependent fashion. This review aims to provide primary care clinicians an updated review of the evidence on metabolic syndrome, with a focus on treatment.

Design: Scoping evidence review.

Eligibility criteria: English-language studies of evidence Level I or II that focused on defining, diagnosing, and treating metabolic syndrome or its components.

Information sources: PubMed and Cochrane Database of Systematic Reviews.

Results: Though evidence is still lacking for improved outcomes with treating the syndrome per se, addressing its individual components reduces risks. Lifestyle changes like weight loss and increased physical activity are first line. Surgical options assist with weight loss for certain patients. Pharmacotherapies like glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors, statins, and antihypertensives also have efficacy.

Conclusions: Metabolic syndrome is an independent risk factor for many poor health outcomes. Its individual components should be treated with medication and behavioral changes to reduce cardiovascular risk and prevent diabetes and its complications. More research is needed on how to treat the syndrome itself. A diagnosis of metabolic syndrome may be useful for motivating patients toward lifestyle changes, though more research is needed on how to treat the syndrome versus its components.

Keywords: chronic disease; metabolic syndrome; preventive medicine; risk reduction behavior.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
PRISMA flow diagram. aConsider, if feasible to do so, reporting the number of records identified from each database or register searched (rather than the total number across all databases/registers). Source: Page MJ, et al. BMJ 2021;372:n71. doi: 10.1136/bmj.n71.

Similar articles

Cited by

References

    1. Noubiap JJ, Nansseu JR, Lontchi-Yimagou E, et al.. Geographic distribution of metabolic syndrome and its components in the general adult population: a meta-analysis of global data from 28 million individuals. Diabetes Res Clin Pract. 2022;188:109924. doi:10.1016/j.diabres.2022.109924 - DOI - PubMed
    1. Noubiap JJ, Nansseu JR, Lontchi-Yimagou E, et al.. Global, regional, and country estimates of metabolic syndrome burden in children and adolescents in 2020: a systematic review and modeling analysis. Lancet Child Adolesc Health. 2022;6:158-170. doi:10.1016/S2352-4642(21)00374-6 - DOI - PubMed
    1. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005;28:2745-2749. doi:10.2337/diacare.28.11.2745 - DOI - PubMed
    1. Riediger ND, Clara I. Prevalence of metabolic syndrome in the Canadian adult population. CMAJ. 2011;183:E1127-E1134. doi:10.1503/cmaj.110070 - DOI - PMC - PubMed
    1. Chen W, Pan Y, Jing J, et al.. Recurrent stroke in minor ischemic stroke or transient ischemic attack with metabolic syndrome and/or diabetes mellitus. J Amer Heart Assoc. 2017;6:e005446. doi:10.1161/JAHA.116.005446 - DOI - PMC - PubMed

LinkOut - more resources